BMJ Case Reports · 2017 · 11 citations · 4 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial PharmacotherapyMedical MicrobiologyMycologyAntifungal PharmacotherapyAntifungal TherapyFungal InfectionsFungal PathogenesisFungal PathologyMedical MycologyCentral Nervous System Fungal InfectionChronic Lymphocytic Leukemia TherapyFungal Infections In Transplant RecipientsInvasive Fungal Infection ManagementInvasive Fungal InfectionsMucormycosis DiagnosisMucormycosis PharmacotherapyMucormycosis Treatment
A 61-year-old man with relapsing chronic lymphocytic leukaemia, status post allogeneic stem cell transplant and multiple chemotherapy regimens presented to the emergency room after suffering a grand mal seizure. His evaluation revealed a 1.5–2 cm ring-enhancing left temporal lobe brain lesion on the CT scan. This brain lesion was resected and the histopathology revealed an invasive fungal organism resembling mucormycosis. Amplification and sequencing of the 28S ribosomal RNA gene identified the organism as Rhizomucor pusillus . The patient was treated with liposomal amphotericin B 5 mg/kg every 24 hours for 4 weeks, and then was transitioned to oral posaconazole. Serial brain imaging at 1 and 3 months, while on therapy, showed significant improvement.
4
Georgios Chamilos, Russell E. Lewis, Dimitrios P. Kontoyiannis · Clinical Infectious Diseases · 2008 · 812 citations · Full text
Laurence Millon, Raoul Herbrecht, Frédéric Grenouillet et al. · Clinical Microbiology and Infection · 2015 · 254 citations
A. Mahadevan, Vijay Laxmi, T.C. Yasha et al. · Mycoses · 2005 · 78 citations